Summary & Overview

HCPCS C9783: Blinded Transcatheter Coronary Sinus Reduction Implantation

HCPCS Level II code C9783 designates a blinded transcatheter procedure for implantation of a coronary sinus reduction device or a placebo control within an approved investigational device exemption (IDE) study. The code packages vascular access and closure, right heart catheterization, venous and coronary sinus angiography, and any imaging guidance, supervision, and interpretation performed under the IDE protocol. This code matters because it standardizes reporting for investigational transcatheter cardiac procedures that evaluate novel therapies to treat conditions involving the coronary sinus, supporting clinical trials, regulatory oversight, and national utilization tracking.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context and typical settings of care, plus what to expect in benchmarking and policy review sections: national utilization benchmarks where available, payer coverage trends and coding guidance relevant to IDE studies, and the clinical workflow elements reflected in the code. The publication also summarizes implications for billing and claims processing when procedures are performed as part of approved investigational studies.

Data not provided in the input: specific associated taxonomies, ICD-10 diagnosis mappings, related billing codes, and payer-specific reimbursement rates.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareC9783HCPCS Level IItranscatheter coronary sinusinvestigational device exemptionright heart catheterizationcardiac angiographyimaging guidanceclinical trial billinginterventional cardiology

Billing Code Overview

HCPCS Level II code C9783 describes a blinded transcatheter procedure for implantation of a coronary sinus reduction device or a placebo control as part of an approved investigational device exemption (IDE) study. The description includes vascular access and closure, right heart catheterization, venous and coronary sinus angiography, and imaging guidance and supervision and interpretation when performed under the approved IDE protocol.

Service Type: Investigational transcatheter coronary sinus reduction implantation or sham procedure

Typical Site of Service: Hospital catheterization laboratory or hybrid operating room, where interventional cardiology procedures and right heart catheterizations are performed.

Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and service line.

Clinical & Coding Specifications

Clinical Context

A 68-year-old patient with chronic ischemic cardiomyopathy and refractory angina despite optimal medical therapy is enrolled in an FDA-approved investigational device exemption (IDE) study evaluating a coronary sinus reduction device. The patient is consented for a blinded transcatheter procedure that may involve device implantation or a placebo control. On the day of procedure the patient is brought to a cardiac catheterization laboratory or hybrid operating room. Vascular access is obtained (typically via the femoral or internal jugular vein), and right heart catheterization is performed to measure intracardiac pressures. Venous and coronary sinus angiography are performed to define coronary sinus anatomy. Under fluoroscopic and/or intracardiac echocardiographic guidance, the operator advances delivery systems into the coronary sinus and performs the blinded step of either implanting the coronary sinus reduction device or simulating the implant for the control arm. Procedure components include imaging guidance, device deployment or sham maneuvers, hemostasis and vascular closure. Post-procedure monitoring occurs in a post-anesthesia care unit or cardiac observation unit with telemetry and access-site assessment. Final documentation includes procedural report, device and study-specific case forms, and supervision/interpretation notes for imaging when performed.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier (base claim)	Used when no special modifier applies; submit with the code as primary indicator of the service.
`22`	Increased procedural services	Report when work, time, or intensity substantially exceeds typical for the blinded transcatheter procedure.
`23`	Unusual anesthesia	Use if general anesthesia was required for unusual circumstances beyond monitored anesthesia care.
`52`	Reduced services	Use when the procedure was partially reduced or limited (for example, aborted before completion of all planned steps).
`53`	Discontinued procedure	Report if the procedure was started but discontinued for patient safety reasons prior to completion.
`62`	Two surgeons	Apply when two surgeons work together as primary surgeons during the procedure.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist service	Use when an assistant-at-surgery from these categories performs services per payer rules.
`CO`	Stem cell transplant beneficiary	(Note: payer-specific) Use per payer guidance when beneficiary is receiving certain covered transplant-related services — rarely applicable.
`CQ`	Service furnished under an FDA investigational device exemption (IDE) study (clinical component)	Use to indicate clinical component services furnished as part of an IDE study for the device arm.
`QK`	Medical direction of two, three, or four concurrent anesthesia procedures involving qualified individuals	Use when the physician medically directed concurrent anesthesia services for multiple cases.

Taxonomy Code	Specialty	Notes
`334200000X`	Interventional Cardiology	Operators who perform coronary sinus device implantation and right heart caths.
`207RC0000X`	Cardiology	General cardiologists participating in procedural care and follow-up.
`363A00000X`	Vascular Surgery	Vascular surgeons may provide vascular access and closure expertise in select centers.
`207L00000X`	Nuclear Cardiology / Cardiac Imaging Specialist	Cardiovascular imaging specialists who interpret angiography and guidance imaging.
`208000000X`	Anesthesiology	Anesthesiologists or CRNAs providing moderate sedation or general anesthesia when required.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I20.8`	Other forms of angina pectoris	Refractory angina is a common indication for coronary sinus reduction device trials.
`I25.10`	Atherosclerotic heart disease of native coronary artery without angina pectoris	Chronic ischemic heart disease often underlies ischemic cardiomyopathy patients considered for coronary sinus therapies.
`I50.22`	Chronic systolic (congestive) heart failure	Patients with ischemic cardiomyopathy and reduced ejection fraction may present with symptoms targeted by coronary sinus remodeling devices.
`I50.9`	Heart failure, unspecified	General heart failure diagnosis encountered in this population when more specific codes are not assigned.
`R07.9`	Chest pain, unspecified	Presenting symptom that may lead to diagnostic evaluation including enrollment in device studies.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`93503`	Insertion and placement of temporary pacing electrode, transvenous, without continuous monitoring; diagnostic catheterization included when performed	May be performed if temporary pacing is required during device deployment or coronary sinus instrumentation.
`93451`	Right heart catheterization including measurement of oxygen saturation and cardiac output, when performed (select codes depend on specifics)	Right heart catheterization components are commonly performed during the coronary sinus device procedure for hemodynamic assessment.
`93458`	Coronary angiography, with right heart catheterization when performed; with coronary angiography, including left heart cath when performed	Coronary and venous angiography image acquisition and interpretation accompany device positioning and angiographic mapping.
`93510`	Right heart catheterization including measurement of intracardiac pressures; with interpretation and report	Captures diagnostic right heart catheterization physiologic measurements frequently done during the procedure.
`92970`	Percutaneous transluminal coronary angioplasty (PTCA); single major coronary artery or branch — when performed alongside PCI in trials	May be reported if concurrent coronary intervention is performed during the same session (report only when clinically performed and documented).